Open AccessUpdate on first African clinical trial on earpopper for the treatment of otitis media with effusion [FCT/UATH/HREC/PR/330]
Author(s) -
Titus S Ibekwe,
Enoch Auta Dahilo,
David Folorunso,
Tochukwu Uzochukwu,
Bosa I Egbe,
Oladeji Raheem Quadri,
Damtong Fred,
Iboro Etukumana,
Basil C Nwankwo,
Ibeneche Onyemuchechi Gbujie
Publication year - 2022
Publication title -
annals of african medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.433
H-Index - 26
ISSN - 1596-3519
DOI - 10.4103/aam.aam_17_21
Subject(s) - medicine , tympanometry , otitis , eustachian tube , serous fluid , effusion , audiometry , conductive hearing loss , myringotomy , prospective cohort study , middle ear , pediatrics , pure tone audiometry , pneumonia , surgery , hearing loss , audiology
Otitis media with effusion (OME) is a middle ear condition characterized by the accumulation of serous fluid. It is common, though not exclusive; among children with its attendant developmental consequence if missed or untreated in early life. OME could be managed surgically, pharmacologically, or physiologically. EarPopper is a medical device developed for physiologic management of OME, Eustachian tube dysfunction, and related problems. We aim to ascertain the suitability/efficiency of EarPopper® device for the treatment of OME in our setting.